Jackson Square Partners LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,236 shares of the medical equipment provider's stock after selling 1,094 shares during the quarter. Jackson Square Partners LLC's holdings in Intuitive Surgical were worth $5,343,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also modified their holdings of ISRG. Meiji Yasuda Asset Management Co Ltd. grew its holdings in shares of Intuitive Surgical by 1.4% during the fourth quarter. Meiji Yasuda Asset Management Co Ltd. now owns 19,132 shares of the medical equipment provider's stock worth $9,986,000 after purchasing an additional 265 shares during the last quarter. Keystone Investors PTE Ltd. purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $13,083,000. Bay Capital Advisors LLC acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $568,000. Signature Estate & Investment Advisors LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $343,000. Finally, First American Trust FSB boosted its holdings in shares of Intuitive Surgical by 65.0% in the fourth quarter. First American Trust FSB now owns 858 shares of the medical equipment provider's stock valued at $448,000 after acquiring an additional 338 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.
Intuitive Surgical Stock Performance
NASDAQ:ISRG traded down $18.56 during mid-day trading on Friday, hitting $489.35. 1,145,477 shares of the company's stock traded hands, compared to its average volume of 1,522,274. The company has a market cap of $174.29 billion, a PE ratio of 76.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm's 50 day simple moving average is $558.29 and its 200 day simple moving average is $532.25. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of recent research reports. Robert W. Baird cut their target price on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, March 18th. UBS Group upped their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Truist Financial decreased their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research note on Monday, March 17th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $611.86.
Check Out Our Latest Stock Analysis on Intuitive Surgical
Insider Activity
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.90% of the stock is currently owned by insiders.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.